Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
09/2003
09/03/2003EP0612318B1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
09/03/2003CN1440404A Benzofuran derivatives and their use as antibacterial agents
09/03/2003CN1440403A Quinazoline ditosylate salt compounds
09/03/2003CN1440402A N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
09/03/2003CN1440400A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides
09/03/2003CN1440399A Coumarin derivatives with COMT inhibiting activity
09/03/2003CN1440392A Phenylpyridazine derivatives and drugs containing the same
09/03/2003CN1440391A Propane-1,3-dione derivatives
09/03/2003CN1439631A Substituted sulfamide (thio) carbonyl compounds
09/03/2003CN1120155C 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals
09/03/2003CN1120041C Reactor comprising contact tube bundle
09/02/2003US6613942 Glucagon antagonists/inverse agonists
09/02/2003US6613905 Chemokine receptor antagonists and methods of use therefor
09/02/2003US6613789 Heterocyclo-substituted imidazoles for the treatment of inflammation
09/02/2003US6613787 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer
09/02/2003US6613780 For therapy and prophylaxis of cancer through thermotherapy and diseases such as depression
09/02/2003US6613776 Protein serine/threonine kinase inhibitors used for treating diseases such as cancer, diabetes and Alzheimer's disease
09/02/2003US6613773 Pyrimidinyloxyphenyl-3-alkoxypropenoates derivatives
09/02/2003US6613764 Aspartic protease inhibitors
09/02/2003US6613743 Sulfonamide inhibitors of aspartyl protease
08/2003
08/28/2003WO2003071280A1 Fluorescent sensor for phosphate ion and phosphorylated peptide
08/28/2003WO2003070855A1 Organic electroluminescent element
08/28/2003WO2003070731A2 Azabicyclic compounds for the treatment of disease
08/28/2003WO2003070723A1 5-heteroaryl substituted indoles
08/28/2003WO2003070710A1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
08/28/2003WO2003070709A1 Novel phenylalanine derivative
08/28/2003WO2003070707A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
08/28/2003WO2003070702A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation, as well as novel processes for preparing atorvastatin hemi-calcium forms i, viii and ix
08/28/2003WO2003070277A1 Antipruritics
08/28/2003WO2003070247A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
08/28/2003WO2003070244A1 Antagonist of melanin concentrating hormone and their uses
08/28/2003WO2003070242A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003WO2003070230A1 Use of agents that modulate pde11a activity
08/28/2003WO2003070182A2 Sodium channel blockers
08/28/2003WO2003045364A3 Use of quinazolines to treat t-cell mediated diseases
08/28/2003WO2003028641A3 Mch receptor antagonists
08/28/2003WO2002102359A3 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity
08/28/2003WO2002036588A3 Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis
08/28/2003US20030162979 Substituted sulphonylamino(thio)carbonyl compounds
08/28/2003US20030162972 Pyridyl alkane acid amides as cytostatics and immunosupressives
08/28/2003US20030162969 Process and intermediates for pyridazinone antidiabetic agents
08/28/2003US20030162814 Amines such as 2-(3-(N-hydroxyamidino)phenylamino)-N-(2'-sulfamoylbiphenyl-4-yl)-2 -methylpropionamide, used as anticoagulants or for prophylaxis of arteriosclerosis, angina pectoris, restinosis or metastasis
08/28/2003US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
08/28/2003US20030162808 Acetindine derivatives, their preparation and medicaments containing them
08/28/2003US20030162784 Pyridazinone aldose reductase inhibitors
08/28/2003US20030162780 Administering to a patient with a disease treatable with a muscarinic receptor antagonist a 1,2,3,4-tetrahydro-naphthalene-2-yl-alkylaminoalkyl-piperidine derivative
08/28/2003US20030162777 Administering a biheterocyclic compounds containing aminocarbonyl, aminothiocarbonyl or aminosulfonyl group for treating neuromuscular dysfunction of the lower urinary tract in a mammal in need of such treatment
08/28/2003US20030162775 Heterocyclic substituted pyrazolones
08/28/2003US20030162774 Derivatives of sulfonylurea, sulfonylthiourea, sulfonylguanidine, thioacylsufonamide and acylsulfonamide; useful for treating thromobis
08/28/2003US20030162771 Have an antagonistic activity with respect to corticotropin releasing factor
08/28/2003US20030162767 Novel 1,3-dihydro-2h-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them
08/28/2003US20030162764 Pyrimidine A2b selective antagonist compounds, their synthesis and use
08/28/2003US20030162661 Selective control of harmful plants in crops of useful plants
08/28/2003US20030162198 Medical diagnosis; complexing to Dna; calibration
08/28/2003CA2477074A1 5-heteroaryl substituted indoles
08/28/2003CA2476936A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
08/28/2003CA2476624A1 Azabicyclic compounds for the treatment of disease
08/28/2003CA2476406A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
08/28/2003CA2475864A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation, as well as novel processes for preparing atorvastatin hemi-calcium forms i, viii and ix
08/28/2003CA2473089A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003CA2419685A1 Antidiabetic agents
08/27/2003EP1337524A1 Substituted quinolines as antitumor agents
08/27/2003EP1337520A1 Substituted 5-aryl and 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole derivatives as uv absorbers
08/27/2003EP1337517A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
08/27/2003EP1337513A1 4-substituted quinolines as antitumor agents
08/27/2003EP1337512A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
08/27/2003EP1337511A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
08/27/2003EP1337510A2 Synthesis and antimicrobial activityof novel dicationic "reversed amidines"
08/27/2003EP1337150A2 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
08/27/2003EP1140944B1 Epothilone derivatives and their use as antitumor agents
08/27/2003EP1140889B1 Compounds and methods for modulation of estrogen receptors
08/27/2003EP1109806B1 Complexes of paroxetine, with cyclodextrins or cyclodextrin derivates
08/27/2003EP1095039B1 New pharmaceutically active compounds
08/27/2003EP1007520B1 2-aminopyridines containing fused ring substituents as nos inhibitors
08/27/2003EP0901469B1 Arylalkylpiperazine compounds as antioxidants
08/27/2003EP0739342B1 Pyridine modulators of acetylcholine receptors
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1439002A Muscarinic agonists
08/27/2003CN1438890A 腺苷受体调制剂 Adenosine receptor modulators
08/27/2003CN1438220A 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative
08/27/2003CN1119336C Novel compounds with analgesic effect
08/26/2003US6610883 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
08/26/2003US6610860 C7 ester substituted taxanes
08/26/2003US6610851 1-tert-butoxycarbonyl-4-(4-fluorophenyl)-3-((3,4-methylene dioxyphenyl)oxymethyl)piperidine; reacting 4-(4-fluorophenyl)-3-hydroxymethylpiperidine with di-tert-butyl dicarbonate to form the carbamate; 3,4-methylenedioxyphenol
08/26/2003US6610737 Non-psychotropic cannabinoids
08/26/2003US6610736 16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/26/2003US6610731 Antiinflammatory
08/26/2003US6610730 Viricides; protease inbhibitor
08/26/2003US6610729 Hydroxamic acid derivatives and medicinal utilization thereof
08/26/2003US6610725 Fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
08/26/2003US6610723 Imidazole derivatives
08/26/2003US6610721 Imidazo heterocyclic compounds
08/26/2003US6610712 Aryloxy piperidinyl derivatives for the treatment of depression
08/26/2003US6610711 4-phenylpiperidines for the treatment of pruritic dermatoses
08/26/2003US6610707 Heterocyclic compounds as inhibitors of rotomase enzymes
08/26/2003US6610692 Anticoagulants
08/26/2003US6610687 Benzofuranylsulfonates
08/26/2003US6610677 Enhancing glycogen synthesis, lowering blood levels of glucose, treating colon, ovarian, or breast cancer, treating diabetes, treating schizophrenia
08/26/2003US6610518 Using Cytochrome p450
08/22/2003CA2418930A1 Use of agents that modulate pde11a activity
1 ... 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 ... 694